| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 39.10B | 43.07B | 34.93B | 31.25B | 30.14B | 27.47B |
| Gross Profit | 7.64B | 8.96B | 6.91B | 6.00B | 5.84B | 5.40B |
| EBITDA | 4.00B | 4.43B | 2.88B | 2.33B | 2.26B | 1.90B |
| Net Income | 1.46B | 1.97B | 692.70M | 626.23M | 741.88M | 459.51M |
Balance Sheet | ||||||
| Total Assets | 40.69B | 39.39B | 38.80B | 35.77B | 31.59B | 29.88B |
| Cash, Cash Equivalents and Short-Term Investments | 9.63B | 12.35B | 10.62B | 10.89B | 10.18B | 10.73B |
| Total Debt | 10.31B | 7.97B | 9.46B | 6.55B | 5.07B | 4.04B |
| Total Liabilities | 18.39B | 16.06B | 17.06B | 14.46B | 10.96B | 9.43B |
| Stockholders Equity | 22.29B | 23.33B | 21.74B | 21.31B | 20.62B | 20.45B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 4.17B | 1.72B | -2.09B | 404.53M | -1.33B |
| Operating Cash Flow | 0.00 | 5.02B | 2.86B | 1.90B | 1.50B | 783.89M |
| Investing Cash Flow | 0.00 | -1.21B | -4.45B | -3.05B | -1.33B | 203.25M |
| Financing Cash Flow | 0.00 | -1.87B | 2.42B | 1.14B | -135.85M | -881.43M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥171.32B | 16.73 | ― | 1.39% | 12.59% | 26.31% | |
75 Outperform | ¥297.30B | 21.26 | ― | 2.42% | 4.46% | 23.01% | |
72 Outperform | ¥16.70B | 8.22 | ― | 3.28% | 23.33% | 182.20% | |
65 Neutral | ¥573.58B | 16.45 | ― | 2.14% | 8.18% | 23.30% | |
64 Neutral | ¥2.82T | 22.84 | 8.35% | 1.77% | 4.75% | 6.22% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥37.94B | 14.21 | ― | 1.95% | 10.26% | -21.50% |